Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.43 USD
−116.14 M USD
258.91 M USD
64.71 M
About MAYNE PHARMA GROUP LIMITED
Sector
CEO
Shawn Patrick O'Brien
Headquarters
Salisbury
Website
Founded
2005
ISIN
AU000000MYX0
FIGI
BBG0046WCK79
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MAYNF is 3.00 USD — it has decreased by −4.61% in the past 24 hours. Watch Mayne Pharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Mayne Pharma Ltd. stocks are traded under the ticker MAYNF.
We've gathered analysts' opinions on Mayne Pharma Ltd. future price: according to them, MAYNF price has a max estimate of 4.11 USD and a min estimate of 3.90 USD. Watch MAYNF chart and read a more detailed Mayne Pharma Ltd. stock forecast: see what analysts think of Mayne Pharma Ltd. and suggest that you do with its stocks.
MAYNF reached its all-time high on Jun 29, 2016 with the price of 34.00 USD, and its all-time low was 1.90 USD and was reached on Oct 4, 2023. View more price dynamics on MAYNF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MAYNF stock is 4.83% volatile and has beta coefficient of 2.40. Track Mayne Pharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Mayne Pharma Ltd. there?
Today Mayne Pharma Ltd. has the market capitalization of 267.87 M, it has decreased by −5.15% over the last week.
Yes, you can track Mayne Pharma Ltd. financials in yearly and quarterly reports right on TradingView.
Mayne Pharma Ltd. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MAYNF earnings for the last half-year are 0.00 USD per share, whereas the estimation was −0.15 USD, resulting in a 100.45% surprise. The estimated earnings for the next half-year are −0.09 USD per share. See more details about Mayne Pharma Ltd. earnings.
Mayne Pharma Ltd. revenue for the last half-year amounts to 133.62 M USD, despite the estimated figure of 134.65 M USD. In the next half-year revenue is expected to reach 136.37 M USD.
MAYNF net income for the last half-year is −69.11 M USD, while the previous report showed −48.03 M USD of net income which accounts for −43.90% change. Track more Mayne Pharma Ltd. financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mayne Pharma Ltd. EBITDA is −6.25 M USD, and current EBITDA margin is −2.41%. See more stats in Mayne Pharma Ltd. financial statements.
Like other stocks, MAYNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mayne Pharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mayne Pharma Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mayne Pharma Ltd. stock shows the sell signal. See more of Mayne Pharma Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.